Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1991 Sep;46(9):633–637. doi: 10.1136/thx.46.9.633

Effect of inhaled prostaglandin E2 on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma.

I D Pavord 1, A Wisniewski 1, R Mathur 1, I Wahedna 1, A J Knox 1, A E Tattersfield 1
PMCID: PMC463348  PMID: 1948791

Abstract

Inhaled frusemide protects against the bronchoconstrictor response to a wide range of stimuli that cause bronchoconstriction by indirect mechanisms. One possible explanation for this protection relates to the known ability of frusemide to enhance synthesis of prostaglandin E2 (PGE2). Studies in vitro suggest that PGE2 might protect against indirectly acting bronchoconstrictor challenges rather than those that act directly on airway smooth muscle, though little is known about the effects of PGE2 in vivo. The effect of inhaled PGE2 on the bronchoconstrictor response to inhaled sodium metabisulphite (a stimulus with an indirect action) and methacholine (which acts directly on airway smooth muscle) was studied in nine patients with asthma. Subjects were studied on four days, inhaling PGE2 (100 micrograms) or placebo in a double blind fashion followed immediately by a cumulative dose challenge with sodium metabisulphite or methacholine. The response to the constrictor stimuli was measured as the provocative dose causing a 20% fall in FEV1 (PD20). There was no significant change in FEV1 after inhaled PGE2 compared with placebo, nor any significant change in the response to methacholine; the geometric mean methacholine PD20 was 0.9 mumol after PGE2 and 0.56 mumol after placebo (mean difference 0.7 (95% confidence limits--0.1, 1.5) doubling doses). PGE2, however, protected against sodium metabisulphite, the geometric mean sodium metabisulphite PD20 being 11.8 mumol after PGE2 and 1.8 mumol after placebo (mean difference 2.5 (95% CL 1.9, 3.1) doubling doses). PGE2 conferred significantly greater protection against sodium metabisulphite than methacholine (mean difference 1.8 (95% CL 0.8, 2.8) doubling doses). This suggests that PGE2, like frusemide, has an inhibitory effect on pathways relevant to the bronchoconstriction induced by sodium metabisulphite, with little or no effect on those relevant to methacholine.

Full text

PDF
633

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bianco S., Pieroni M. G., Refini R. M., Rottoli L., Sestini P. Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions. N Engl J Med. 1989 Oct 19;321(16):1069–1073. doi: 10.1056/NEJM198910193211602. [DOI] [PubMed] [Google Scholar]
  2. Bianco S., Vaghi A., Robuschi M., Pasargiklian M. Prevention of exercise-induced bronchoconstriction by inhaled frusemide. Lancet. 1988 Jul 30;2(8605):252–255. doi: 10.1016/s0140-6736(88)92540-8. [DOI] [PubMed] [Google Scholar]
  3. Choudry N. B., Fuller R. W., Pride N. B. Sensitivity of the human cough reflex: effect of inflammatory mediators prostaglandin E2, bradykinin, and histamine. Am Rev Respir Dis. 1989 Jul;140(1):137–141. doi: 10.1164/ajrccm/140.1.137. [DOI] [PubMed] [Google Scholar]
  4. Churchill L., Chilton F. H., Resau J. H., Bascom R., Hubbard W. C., Proud D. Cyclooxygenase metabolism of endogenous arachidonic acid by cultured human tracheal epithelial cells. Am Rev Respir Dis. 1989 Aug;140(2):449–459. doi: 10.1164/ajrccm/140.2.449. [DOI] [PubMed] [Google Scholar]
  5. Dixon C. M., Ind P. W. Inhaled sodium metabisulphite induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate. Br J Clin Pharmacol. 1990 Sep;30(3):371–376. doi: 10.1111/j.1365-2125.1990.tb03786.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gardiner P. J. Characterization of prostanoid relaxant/inhibitory receptors (psi) using a highly selective agonist, TR4979. Br J Pharmacol. 1986 Jan;87(1):45–56. doi: 10.1111/j.1476-5381.1986.tb10155.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hardy C. C., Bradding P., Robinson C., Holgate S. T. Bronchoconstrictor and antibronchoconstrictor properties of inhaled prostacyclin in asthma. J Appl Physiol (1985) 1988 Apr;64(4):1567–1574. doi: 10.1152/jappl.1988.64.4.1567. [DOI] [PubMed] [Google Scholar]
  8. Haye-Legrand I., Cerrina J., Raffestin B., Labat C., Boullet C., Bayol A., Benveniste J., Brink C. Histamine contraction of isolated human airway muscle preparations: role of prostaglandins. J Pharmacol Exp Ther. 1986 Nov;239(2):536–541. [PubMed] [Google Scholar]
  9. Hubscher T. Role of the eosinophil in the allergic reactions. II. Release of prostaglandins from human eosinophilic leukocytes. J Immunol. 1975 Apr;114(4):1389–1393. [PubMed] [Google Scholar]
  10. Ito I., Suzuki H., Aizawa H., Hirose T., Hakoda H. Pre-junctional inhibitory action of prostaglandin E2 on excitatory neuro-effector transmission in the human bronchus. Prostaglandins. 1990 Jun;39(6):639–655. doi: 10.1016/0090-6980(90)90024-p. [DOI] [PubMed] [Google Scholar]
  11. Johnston G. D., Hiatt W. R., Nies A. S., Payne N. A., Murphy R. C., Gerber J. G. Factors modifying the early nondiuretic vascular effects of furosemide in man. The possible role of renal prostaglandins. Circ Res. 1983 Nov;53(5):630–635. doi: 10.1161/01.res.53.5.630. [DOI] [PubMed] [Google Scholar]
  12. MacDermot J., Kelsey C. R., Waddell K. A., Richmond R., Knight R. K., Cole P. J., Dollery C. T., Landon D. N., Blair I. A. Synthesis of leukotriene B4, and prostanoids by human alveolar macrophages: analysis by gas chromatography/mass spectrometry. Prostaglandins. 1984 Feb;27(2):163–179. doi: 10.1016/0090-6980(84)90071-6. [DOI] [PubMed] [Google Scholar]
  13. Manning P. J., Lane C. G., O'Byrne P. M. The effect of oral prostaglandin E1 on airway responsiveness in asthmatic subjects. Pulm Pharmacol. 1989;2(3):121–124. doi: 10.1016/0952-0600(89)90035-5. [DOI] [PubMed] [Google Scholar]
  14. Mathé A. A., Hedqvist P. Effect of prostaglandins F2 alpha and E2 on airway conductance in healthy subjects and asthmatic patients. Am Rev Respir Dis. 1975 Mar;111(3):313–320. doi: 10.1164/arrd.1975.111.3.313. [DOI] [PubMed] [Google Scholar]
  15. Mattoli S., Foresi A., Corbo G. M., Valente S., Ciappi G. The effect of indomethacin on the refractory period occurring after the inhalation of ultrasonically nebulized distilled water. J Allergy Clin Immunol. 1987 Apr;79(4):678–683. doi: 10.1016/s0091-6749(87)80165-3. [DOI] [PubMed] [Google Scholar]
  16. NADEL J. A., SALEM H., TAMPLIN B., TOKIWA Y. MECHANISM OF BRONCHOCONSTRICTION DURING INHALATION OF SULFUR DIOXIDE. J Appl Physiol. 1965 Jan;20:164–167. doi: 10.1152/jappl.1965.20.1.164. [DOI] [PubMed] [Google Scholar]
  17. Nichol G. M., Alton E. W., Nix A., Geddes D. M., Chung K. F., Barnes P. J. Effect of inhaled furosemide on metabisulfite- and methacholine-induced bronchoconstriction and nasal potential difference in asthmatic subjects. Am Rev Respir Dis. 1990 Sep;142(3):576–580. doi: 10.1164/ajrccm/142.3.576. [DOI] [PubMed] [Google Scholar]
  18. Nichol G. M., Nix A., Chung K. F., Barnes P. J. Characterisation of bronchoconstrictor responses to sodium metabisulphite aerosol in atopic subjects with and without asthma. Thorax. 1989 Dec;44(12):1009–1014. doi: 10.1136/thx.44.12.1009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. O'Byrne P. M., Jones G. L. The effect of indomethacin on exercise-induced bronchoconstriction and refractoriness after exercise. Am Rev Respir Dis. 1986 Jul;134(1):69–72. doi: 10.1164/arrd.1986.134.1.69. [DOI] [PubMed] [Google Scholar]
  20. Pasargiklian M., Bianco S., Allegra L. Clinical, functional and pathogenetic aspects of bronchial reactivity to prostaglandins F2alpha, E1, and E2. Adv Prostaglandin Thromboxane Res. 1976;1:461–475. [PubMed] [Google Scholar]
  21. Pasargiklian M., Bianco S., Allegra L., Moavero N. E., Petrigni G., Robuschi M., Grugni A. Aspects of bronchial reactivity to prostaglandins and aspirin in asthmatic patients. Respiration. 1977;34(2):78–91. [PubMed] [Google Scholar]
  22. Polosa R., Lau L. C., Holgate S. T. Inhibition of adenosine 5'-monophosphate- and methacholine-induced bronchoconstriction in asthma by inhaled frusemide. Eur Respir J. 1990 Jun;3(6):665–672. [PubMed] [Google Scholar]
  23. Robuschi M., Gambaro G., Spagnotto S., Vaghi A., Bianco S. Inhaled frusemide is highly effective in preventing ultrasonically nebulised water bronchoconstriction. Pulm Pharmacol. 1989;1(4):187–191. doi: 10.1016/s0952-0600(89)80016-x. [DOI] [PubMed] [Google Scholar]
  24. Seth R. V., Clarke V. S., Lewis R. A., Tattersfield A. E. Effect of propranolol on the airway response to prostaglandin E2 in normal man. Br J Clin Pharmacol. 1981 Nov;12(5):731–735. doi: 10.1111/j.1365-2125.1981.tb01297.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Smith A. P., Cuthbert M. F., Dunlop L. S. Effects of inhaled prostaglandins E1, E2, and F2alpha on the airway resistance of healthy and asthmatic man. Clin Sci Mol Med. 1975 May;48(5):421–430. doi: 10.1042/cs0480421. [DOI] [PubMed] [Google Scholar]
  26. Sweatman W. J., Collier H. O. Effects of prostaglandins on human bronchial muscle. Nature. 1968 Jan 6;217(5123):69–69. doi: 10.1038/217069a0. [DOI] [PubMed] [Google Scholar]
  27. Walters E. H., Davies B. H. Dual effect of prostaglandin E2 on normal airways smooth muscle in vivo. Thorax. 1982 Dec;37(12):918–922. doi: 10.1136/thx.37.12.918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Walters E. H., O'Byrne P. M., Fabbri L. M., Graf P. D., Holtzman M. J., Nadel J. A. Control of neurotransmission by prostaglandins in canine trachealis smooth muscle. J Appl Physiol Respir Environ Exerc Physiol. 1984 Jul;57(1):129–134. doi: 10.1152/jappl.1984.57.1.129. [DOI] [PubMed] [Google Scholar]
  29. Welch S. P., Singha A. K., Dewey W. L. The antinociception produced by intrathecal morphine, calcium, A23187, U50,488H, [D-Ala2, N-Me-Phe4, Gly-ol]enkephalin and [D-Pen2, D-Pen5]enkephalin after intrathecal administration of calcitonin gene-related peptide in mice. J Pharmacol Exp Ther. 1989 Oct;251(1):1–8. [PubMed] [Google Scholar]
  30. Wright W., Zhang Y. G., Salome C. M., Woolcock A. J. Effect of inhaled preservatives on asthmatic subjects. I. Sodium metabisulfite. Am Rev Respir Dis. 1990 Jun;141(6):1400–1404. doi: 10.1164/ajrccm/141.6.1400. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES